Atlas Trials

Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)

Clinical trial NCT04157335 · TERMINATED

Trial details

NCT number
NCT04157335
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Nasal PolyposisEosinophilic Chronic Rhinosinusitis
Start date
2019-11-25
Primary completion
2024-08-06
Enrollment
295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.